Condition: Relapsed/Refractory Non-Hodgkin Lymphoma · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary biological and clinical activity of BMS-986458, a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma agents in participants with relapsed/refractory non-Hodgkin Lymphoma.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Arizona - Phoenix | Phoenix, Arizona, United States | Recruiting |
| City of Hope Comprehensive Cancer Center | Duarte, California, United States | Recruiting |
| Local Institution - 0068 | Jacksonville, Florida, United States | Not Yet Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic in Rochester, Minnesota | Rochester, Minnesota, United States | Recruiting |
| Local Institution - 0124 | Omaha, Nebraska, United States | Not Yet Recruiting |
| Local Institution - 0047 | Lake Success, New York, United States | Completed |
| Local Institution - 0037 | New York, New York, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Local Institution - 0045 | Providence, Rhode Island, United States | Not Yet Recruiting |
| Local Institution - 0118 | Antofagasta, AN, Chile | Not Yet Recruiting |
+ 55 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06090539